Sign in

CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
  1. 4 Grant or award Director acquired 1,045 shares (grant or award)
  2. 4 Grant or award Director acquired 1,045 shares (grant or award)
  3. 4 Grant or award Director acquired 1,045 shares (grant or award)
  4. 4 Grant or award Director acquired 1,045 shares (grant or award)
  5. 4 Grant or award Director acquired 1,045 shares (grant or award)
  6. 4 Open-market buy President/CEO bought 5,500 shares at an average $1.84 ($10,110)
  7. 4 Grant or award SrVP/CFO/Prin Fin & Acct Ofcr acquired 3,365 shares (grant or award)
  8. 4 Grant or award President/CEO acquired 6,725 shares (grant or award)
  9. 4 Open-market sale Director sold 6,462 shares at $4.58 ($29,583)
  10. 4 Open-market buy President/CEO bought 500 shares at $3.92 ($1,958)
  11. 4 Open-market buy Director bought 30,000 shares at $4.39 ($131,700)
  12. 4 Open-market buy President/CEO bought 250 shares at $2.90 ($725)
  13. 4 Open-market buy Director bought 190 shares at $2.58 ($490)
  14. 4 Open-market buy SrVP/CFO/Prin Fin & Acct Ofcr bought 50 shares at $2.46 ($123)
  15. 4 Open-market buy Director bought 10,000 shares at $2.68 ($26,800)
  16. 4 Open-market buy President/CEO bought 1,150 shares at an average $2.58 ($2,971)
  17. 4 Open-market buy SrVP/CFO/Prin Fin & Acct Ofcr bought 450 shares at $2.61 ($1,175)
  18. 4 Grant or award Director acquired 1,045 shares (grant or award)
  19. 4 Grant or award Director acquired 1,045 shares (grant or award)
  20. 4 Grant or award Director acquired 1,045 shares (grant or award)

Page 2 of 9 · 180 filings